Effectdossier · gearchiveerd kwartaal
NRIX
Nurix Therapeutics, Inc. · Healthcare · Biotechnology
14Gevolgde houders
-2Δ houders
38.82MGehouden aandelen
$442.11MGerapporteerde waarde
+0Nieuwe posities
−2Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders -12.5% ·
aandelenstroom +4.8% ·
netto nieuwe posities -14.3%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +2 | 57.55M | $1.40B | +9 | −7 |
| Q1 2026 | 81 | +9 | 58.06M | $899.96M | +14 | −5 |
| Q4 2025 | 72 | -4 | 55.79M | $1.06B | — | −4 |
| Q3 2025 | 18 | +1 | 36.35M | $335.90M | +1 | — |
| Q2 2025 | 14 | -2 | 38.82M | $442.11M | — | −2 |
| Q1 2025 | 13 | 0 | 15.31M | $181.88M | +1 | −1 |
| Q4 2024 | 13 | -1 | 15.53M | $292.61M | +1 | −2 |
| Q3 2024 | 13 | -1 | 13.04M | $292.98M | +1 | −2 |
| Q2 2024 | 14 | — | 12.64M | $263.85M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 10.44M | — | $118.94M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 10.44M | — | $118.94M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 10.44M | — | $118.94M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 10.44M | — | $118.94M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 10.44M | — | $118.94M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 6.81M | — | $77.55M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 4.47M | — | $50.86M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 4.47M | — | $50.86M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 4.47M | — | $50.86M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 4.47M | — | $50.86M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 4.47M | — | $50.86M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Point72 Asset Management ✦ | 3.70M | +1595.4% | $42.18M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 3.03M | +4.1% | $34.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 3.03M | +4.1% | $34.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | State Street Global Advisors ✦ (passief) | 2.53M | -11.5% | $28.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | Geode Capital Management ✦ (passief) | 1.88M | +9.1% | $21.44M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Geode Capital Management ✦ (passief) | 1.88M | +9.1% | $21.44M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 1.59M | +20.6% | $18.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 1.59M | +20.6% | $18.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | ARK Investment Management ✦ | 1.58M | -1.0% | $17.94M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 1.47M | -54.1% | $16.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 1.47M | -54.1% | $16.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 1.47M | -54.1% | $16.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 1.47M | -54.1% | $16.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 1.47M | -54.1% | $16.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 1.47M | -54.1% | $16.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Millennium Management ✦ | 927.56K | +6.1% | $10.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | PRIMECAP Management ✦ | 210.00K | -9.5% | $2.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 158.72K | -38.4% | $1.81M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | Renaissance Technologies ✦ | 21.90K | -63.2% | $249,441 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| D. E. Shaw & Co. | $711,885 | was 0.0% |
| AQR Capital Management | $138,615 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 194 houders, 116.98M aandelen, $1.75B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API